Berry Street, a nutrition care company, has merged with India-based Healthify to form what executives call the largest insurance-covered AI metabolic health platform in the U.S.
The merger combines Healthify’s AI technology, including its nutrition and metabolic health assistant Ria, with Berry Street’s nationwide network of more than 2,000 clinicians and insurance-covered nutrition and GLP-1 care. The companies say the goal is to offer AI-powered, clinician-backed metabolic health support that is accessible through health insurance.
Financial details of the merger were not disclosed. Berry Street shared the news exclusively with Fierce Healthcare.
Healthify, a company that is more than a decade old, has grown to become a large AI consumer health player, serving more than 45 million users across more than 20 cultures worldwide. The company initially started by matching patients with dietitians for nutritional therapy.
"They were very early in developing AI to enhance the care that they were delivering. When I met them late last year, they were looking for a partner to launch in the U.S. They had really perfected this combination of AI plus human clinician-in-the-loop for clinically proven outcomes," Noah Kotlove, founder and CEO of Berry Street, told Fierce Healthcare.
"When I met them and played with their product, I realized very quickly, 'Wow, I'm looking at the next one to two years of our roadmap.' We shared the same vision for where the future of metabolic health was going and how AI would play a part in that, and so we thought why not join in forces and pair their best-in-class consumer AI product with the large, high-quality insurance-covered clinician network that we had spent the last few years building here in the U.S," Kotlove said.
The combined company will be led by Kotlove and Healthify CEO Tushar Vashisht as co-CEOs. In the U.S., the company will continue to operate under the Berry Street brand. Outside the U.S., including in India and other markets where Healthify has established a strong consumer presence, the Healthify brand will remain, executives said.
Berry Street started in 2023 with a "very simple idea," Kotlove said. "Most Americans have extremely generous coverage through their existing health insurance to work with a registered dietitian one-on-one for all sorts of chronic and acute conditions, and of course nutrition is upstream of basically any illness that that we might suffer from. In a few years, we scaled one of the largest and highest-quality networks of registered dietitians in the country across all 50 states, where patients can meet with their dietitians, in most cases, completely for free for $0 out of pocket."
In February 2025, Berry Street landed a $50 million funding round from Northzone, Sofina and FJ Labs.
The company delivers personalized, evidence-based metabolic care through its nationwide network of 2,000-plus clinicians and has served more than 200,000 patients through collaborations with Amazon, Walmart, and other health plans and consumer platforms.
Last year, Berry Street expanded into the obesity and weight management market by launching its comprehensive GLP-1 Nutrition Pathway Program. "Naturally, given our focus on nutrition, a large percentage of our patients come to us for weight management and metabolic health. With GLP-1 weight loss drugs, that tidal wave has hit the healthcare shores here in the U.S., so we launched a GLP-1 program where patients can patients can work with a doctor one-on-one, all through their insurance, and get access to FDA-approved weight loss medications," Kotlove said.
One in eight Americans is now on a GLP-1, according to KFF data. "The science is clear: these medications are most effective when paired with high-touch clinical oversight and expert nutrition guidance. But for most Americans, that experience has been out of reach," Kotlove said.
"Healthify’s mission has been to put a dietitian in every human’s pocket. We have spent a decade proving that AI can drive life-changing outcomes at scale," Vashisht said in a statement. "Berry Street gives us the clinical backbone and the coverage infrastructure to deliver that promise to the U.S. market at a scale no one has achieved before. This is the combination the industry has been waiting for."
Berry Street patients meet synchronously with a care team of registered dietitians, doctors and nurse practitioners for GLP-1 management and ongoing nutrition therapy. Between visits, patients use the Berry Street app for AI-powered guidance, meal tracking, and integration of health data from wearables and lab results. Berry Street supports more than 30 conditions, ranging from weight loss and diabetes to women’s health and heart health.
Healthify’s platform has been honed on hundreds of millions of real dietitian-to-patient interactions, enabling it to synthesize signals across nutrition, sleep, stress, and weight in real time. Healthify also built out a GLP-1 weight management initiative, which includes a patient support program with Novo Nordisk, now the company's fastest-growing offering.
Berry Street is among the first cohort of the Centers for Medicare and Medicaid Services' ACCESS model, a new 10-year program for value-based chronic condition management that leans heavily on technology and artificial intelligence to scale to large populations of patients.
"We're excited about the opportunity to pair the human clinical expertise that we've scaled to this point with AI to impact many more lives at a much lower cost," Kotlove said.
The CMS ACCESS model, which kicked off last month, offers the "perfect canvas" for Berry Street to "take what Healthify has already built and leverage it here in the U.S. to make an impact on patients' lives," he noted.
With the new ACCESS model, reimbursement rates are intentionally low, making it difficult to rely heavily on human clinical labor alone, Kotlove said. "We're excited about using their product and applying their technology to one of the largest and highest-need populations in healthcare: Medicare beneficiaries in the cardio-kidney-metabolic tracks," he said.
Consumers are increasingly turning to AI for health advice, but Berry Street and Healthify are betting that the winning model isn't AI alone, it's AI wrapped with clinicians, insurance coverage and medical oversight.
One in three Americans now turn to AI for health guidance, double the share from just a year ago, according to survey data from Rock Health. The number seeking diet and weight loss support is growing rapidly alongside the GLP-1 boom. But most of that guidance comes from general-purpose AI tools that lack clinical credibility and evidence-based outcomes.
Healthify offers an AI nutrition coach, called Ria, that is multimodal and multilingual, with patented food-logging technology that can track nutrition from a photograph in under one second, without the user ever opening the app. A peer-reviewed study published with Stanford Medical School, the first paper to examine AI-only metabolic health outcomes, demonstrated measurable improvements in weight and metabolic markers among Ria users.
"That track record sets up this product and now this joint company for what we believe is going to be the most impactful metabolic health company in the world," Kotlove asserted.
The combined capabilities of the two companies hit on three major trends shaping the healthcare market—AI, GLP-1 weight loss drugs and the consumerization of healthcare.
"For a variety of reasons, patients in the U.S. are taking a much more active role in their healthcare, and you see that in the companies that are dominating the headlines today. We're meeting that consumer demand with a best-in-class AI product alongside an insurance-covered GLP-1 offering, and, most importantly, pairing that with that one-on-one coaching and more therapeutic layer to give patients that full wraparound experience," Kotlove said.
“By pairing AI with a nationwide network of expert clinicians, Healthify and Berry Street are building the platform that will redefine metabolic care, giving everyone access to daily nutrition guidance and expert dietitian advice,” said Vinod Khosla, founder of Khosla Ventures.
Berry Street plans to integrate Healthify's AI nutrition coaching tool into the Berry Street digital experience for patients while also focusing on Healthify's continued growth in India. "It's the largest country and economy in the world and also has a very fast-rising obesity rate and chronic disease rate," Kotlove noted, adding that Healthify plans to expand into other geographies as GLP-1 drugs continue to grow.
The use of AI also helps the combined company scale up nutrition therapy to more patients. "Clinical labor is always in short supply here in the U.S. and globally. If we want to give as many people as possible the best outcomes at the lowest cost and increase that access, then we are big believers in the power of AI to get us there," Kotlove noted.